Latest News about biotech
Recent news which mentions biotech
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
November 19, 2024
From Benzinga
Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst
November 19, 2024
From Benzinga
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
November 19, 2024
From Benzinga
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
November 19, 2024
From Benzinga
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
November 19, 2024
From Benzinga
From Benzinga
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
November 19, 2024
From Benzinga
EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential
November 19, 2024
From Benzinga
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
From Benzinga
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
November 18, 2024
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
From Benzinga
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
November 18, 2024
From Benzinga
Why Is Penny Stock HCW Biologics Surging On Monday?
November 18, 2024
From Benzinga
From Benzinga
JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
November 15, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.